Breast Cancer Information

Recommendations For Early Breast Cancer Screening


Women need to empower themselves about the benefits and risks of mammography and examine the additional screening tools available today. One current philosophy suggests breast health screening should begin at age 25. Where does this recommendation come from and why is this valid?

For MOST women, the recommendation for annual breast cancer screening begins at the age of 40. Unfortunately, the American Cancer Society stated that the number one cause of death in women between the ages of 40-44 is breast cancer. So what does this mean for women? It means that we screen at age 40 and potentially find tumors that have been growing for an estimated 8-10 years. Mammography, like most conventional tests, evaluates structure.

There exists a technology that can detect an issue YEARS before a tumor can be seen on X-ray or palpated during an exam. This technology has been approved by the FDA as an adjunctive screening tool since 1982 and offers NO RADIATION, NO COMPRESSION AND NO PAIN. For women who are refusing to have a mammogram or those who want clinical correlation for an existing problem, digital infrared thermal imaging may be of interest.

There are very strict protocols both for testing and interpreting. Perhaps due to these guidelines, thermography (as with all digital technology) has exploded in its technique and capabilities. Thermal cameras detect heat emitted from the body and display it as a picture on a computer monitor. These images are unique to the person and remain stable over time. It is because of these characteristics that thermal imaging is a valuable and effective screening tool. Tumors or other breast diseases measures warmer than surrounding tissue and can thereby alert a physician to a problem before a tumor is actually palpable.

Medical doctors who interpret the breast scans are board certified and endure an additional two years of training to qualify as a thermologist. Thermography is not limited by breast density and is ideal for women who have had cosmetic or reconstructive surgery. It is recommended that since cancer typically has a 15 year life span from onset to death, women begin thermographic screenings at age 25. As previously mentioned, the number one killer of women ages 40-44 is breast cancer. Therefore, a woman diagnosed with breast cancer at age 40 possibly had the cancer as early as age 30. Since most women do not have a mammogram until age 40, there is a critical time period from age 25 to 39 that thermography could be especially beneficial. Thermography, because it analyzes function, may identify a problem years earlier. DITI may allow women time and opportunity to support their immune system, change their lifestyle and give their body the best chance to alter their fate.

By combining both technologies, the detection rate increases to 95-98%, surpassing either technology as a stand-alone therapy. Thermography, like mammography, is a personal choice for women. This decision ideally should be made in collaboration between you and your physician. However, thermography does not require a physician's order.

Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com.

Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She is an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area.


MORE RESOURCES:
Google

The Money Times

Low Levels of Vitamin D Spell Trouble for Breast Cancer Patients
U.S. News & World Report, DC - 1 hour ago
By Amanda Gardner FRIDAY, May 16 (HealthDay News) -- Women with breast cancer who have a vitamin D deficiency at the time of diagnosis are more likely to ...
Vitamin D deficiency linked to poorer breast cancer outcomes: study The Canadian Press
Breast cancer linked to Vitamin D deficiency Hindu
More Aggressive Breast Cancer Linked to Vitamin D Deficiency ABC News
Los Angeles Times - Globe and Mail
all 195 news articles


Victim of bungled breast cancer tests urges others to get second ...
The Canadian Press, TORONTO - 1 hour ago
TORONTO ? For most women, there are few more terrifying words to hear than: "You have breast cancer." Unless, of course, it's being told the recommended ...


Blood Test Helps Docs Assess Breast Cancer Treatment
U.S. News & World Report, DC - 1 hour ago
In this study, Liu and colleagues measured the number of circulating tumor cells (CTC) in blood samples collected from metastatic breast cancer patients ...


AFP

Vitamin D deficiency linked to breast cancer in new study
AFP - 4 hours ago
WASHINGTON (AFP) ? Women deficient in vitamin D at the time of a breast cancer diagnosis are more likely to die or see the tumor spread, a Canadian study ...


GlxoSmithKline: Drug combo study shows positive result in treating ...
Forbes, NY - 16 minutes ago
... data from a Phase III trial of the combination of two targeted agents, Tykerb and trastuzumab, in women with HER2-positive metastatic breast cancer. ...


KLEW

Physical activity may prevent breast cancer
Times of India, India - 8 hours ago
A new study has found that women who engage in physical activity are 25 per cent less likely to develop breast cancer. However, researchers also discovered ...
Link Between Vitamin D Status And Breast Cancer Illuminated Science Daily (press release)
Exercise when young may cut breast cancer Los Angeles Times
Regular Aspirin Intake Cuts Breast Cancer Risk Medi News Direct
HealthJockey.com - Medscape (subscription)
all 508 news articles


Vitamin D may help curb breast cancer, study finds
The Associated Press - 9 hours ago
Breast cancer patients with low levels of vitamin D were much more likely to die of the disease or have it spread than patients getting enough of the ...


Eisai says drug active in advanced breast cancer
Reuters - 9 hours ago
T: Quote, Profile, Research) said on Friday that its experimental treatment for advanced breast cancer had shown tumour fighting activity in mid-stage ...


Brocktown News

Herceptin enhances Tykerb for breast cancer -study
guardian.co.uk, UK - 13 hours ago
Both drugs are designed to treat, in different ways, the 25 percent to 30 percent of breast cancer patients who have tumors that generate a protein called ...
Drug combo helps women with advanced breast cancer The Associated Press
Drug combo helps women with advanced breast cancer XETV FOX6 San Diego
Drug combo helps women with advanced breast cancer WBXH
all 156 news articles


Failed lung cancer drug has breast cancer promise
guardian.co.uk, UK - 13 hours ago
Combining Iressa with the breast cancer drug Arimidex helped women survive 45 percent longer without the cancer coming back than using Arimidex alone, ...

Breast-Cancer - Google News

home | site map
© 2006